VEMURAFENIB

VEMURAFENIB was reported 11991 times

VEMURAFENIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 RADIOSENSITISATION THERAPY 4 0.5714
1 EPIDERMAL NAEVUS SYNDROME 4 0.4000
2 NEUTROPHILIC PANNICULITIS 17 0.2361
3 HAIRY CELL LEUKAEMIA RECURRENT 9 0.2195
4 KERATOACANTHOMA 105 0.1535
5 KERATOSIS PILARIS 34 0.1360
6 LIVER PALPABLE 8 0.1127
7 ECCRINE SQUAMOUS SYRINGOMETAPLASIA 4 0.1111
8 BRAF GENE MUTATION 9 0.1000
9 SEROUS RETINOPATHY 9 0.0857
10 ACANTHOMA 4 0.0769
11 SOLAR DERMATITIS 20 0.0741
12 PANNICULITIS LOBULAR 6 0.0674
13 BRAF V600E MUTATION POSITIVE 4 0.0656
14 RASH FOLLICULAR 10 0.0649
15 SEPTAL PANNICULITIS 5 0.0625
16 ACANTHOLYSIS 4 0.0606
17 PAPILLOMA 19 0.0599
18 SKIN PAPILLOMA 234 0.0583
19 CARDIAC NEOPLASM MALIGNANT 4 0.0563
20 SUNBURN 373 0.0500
21 METASTATIC MALIGNANT MELANOMA 103 0.0448
22 MELANOSIS 5 0.0446
23 HAIRY CELL LEUKAEMIA 10 0.0429
24 SEROUS RETINAL DETACHMENT 33 0.0394
25 ACROCHORDON 48 0.0362
26 INTRACRANIAL TUMOUR HAEMORRHAGE 14 0.0362
27 HYPERKERATOSIS 192 0.0348
28 MELANOCYTIC NAEVUS 138 0.0314
29 SKIN TOXICITY 176 0.0311
30 GASTROINTESTINAL LYMPHOMA 8 0.0308
31 TRANSIENT ACANTHOLYTIC DERMATOSIS 9 0.0306
32 CHORIORETINOPATHY 43 0.0302
33 OVERGROWTH BACTERIAL 8 0.0297
34 SIDEROBLASTIC ANAEMIA 4 0.0286
35 BACTERIAL DIARRHOEA 6 0.0284
36 ORGANIC BRAIN SYNDROME 5 0.0266
37 PALMOPLANTAR KERATODERMA 19 0.0262
38 MELANOMA RECURRENT 11 0.0261
39 MUCOCUTANEOUS RASH 4 0.0260
40 RADIATION SKIN INJURY 30 0.0259
41 SQUAMOUS CELL CARCINOMA 239 0.0254
42 PHOTOSENSITIVITY REACTION 415 0.0251
43 MILIA 9 0.0248
44 PANNICULITIS 59 0.0244
45 SUPERFICIAL SPREADING MELANOMA STAGE UNSPECIFIED 6 0.0236
46 AUTOIMMUNE COLITIS 15 0.0233
47 PERIPHERAL NERVE LESION 7 0.0212
48 RADIATION NECROSIS 12 0.0209
49 BENIGN NEOPLASM OF SKIN 7 0.0208
50 EPIDURAL LIPOMATOSIS 7 0.0203
51 BRAIN TUMOUR OPERATION 4 0.0200
52 SQUAMOUS CELL CARCINOMA OF SKIN 120 0.0199
53 METASTASES TO CENTRAL NERVOUS SYSTEM 246 0.0191
54 ACANTHOSIS 6 0.0183
55 VOGT-KOYANAGI-HARADA DISEASE 4 0.0182
56 ANAPLASTIC ASTROCYTOMA 3 0.0182
57 ENANTHEMA 10 0.0174
58 RELAPSING FEVER 5 0.0173
59 MASS 237 0.0169
60 METASTASES TO GASTROINTESTINAL TRACT 4 0.0166
61 PHOTODERMATOSIS 7 0.0166
62 NEUTROPHILIC DERMATOSIS 6 0.0152
63 SEBORRHOEIC KERATOSIS 22 0.0151
64 MALIGNANT MELANOMA IN SITU 18 0.0145
65 CUTANEOUS SARCOIDOSIS 6 0.0139
66 NEOPLASM SKIN 21 0.0135
67 DERMATITIS ACNEIFORM 82 0.0135
68 SCAR PAIN 5 0.0124
69 HYPERCREATINAEMIA 4 0.0121
70 RECALL PHENOMENON 10 0.0120
71 FAT NECROSIS 7 0.0115
72 SKIN MASS 77 0.0115
73 FIBROUS HISTIOCYTOMA 4 0.0114
74 XEROSIS 14 0.0113
75 DYSPLASTIC NAEVUS 4 0.0111
76 ENTEROBACTER SEPSIS 4 0.0108
77 NODAL ARRHYTHMIA 9 0.0105
78 DEFAECATION DISORDER 7 0.0104
79 IRIDOCYCLITIS 32 0.0101
80 OCULAR TOXICITY 11 0.0100
81 MALIGNANT MELANOMA 131 0.0098
82 IRIS ADHESIONS 5 0.0097
83 METASTASES TO SPLEEN 4 0.0097
84 ACTINIC KERATOSIS 25 0.0096
85 RASH MACULO-PAPULAR 212 0.0095
86 RETINOPATHY 34 0.0091
87 LIMB MASS 20 0.0091
88 UVEITIS 121 0.0089
89 CENTRAL SEROUS CHORIORETINOPATHY 6 0.0088
90 PERIPHERAL MOTOR NEUROPATHY 12 0.0086
91 HYPOPHYSITIS 17 0.0084
92 DERMAL CYST 20 0.0081
93 ERYTHEMA NODOSUM 28 0.0080
94 DETACHMENT OF RETINAL PIGMENT EPITHELIUM 7 0.0079
95 OROPHARYNGEAL CANDIDIASIS 7 0.0077
96 NEOPLASM 88 0.0076
97 TOXIC SKIN ERUPTION 76 0.0075
98 SKIN HYPOPIGMENTATION 13 0.0073
99 PSEUDOLYMPHOMA 4 0.0072
100 RASH MORBILLIFORM 20 0.0072
101 METASTASES TO MENINGES 16 0.0070
102 TUMOUR HAEMORRHAGE 20 0.0070
103 BLOOD LACTATE DEHYDROGENASE INCREASED 110 0.0069
104 LIP ULCERATION 8 0.0068
105 ALVEOLAR PROTEINOSIS 4 0.0068
106 ERYTHEMA MULTIFORME 62 0.0066
107 RADIATION INJURY 7 0.0066
108 DISEASE PROGRESSION 768 0.0065
109 NIPPLE DISORDER 4 0.0064
110 DERMATITIS EXFOLIATIVE 32 0.0064
111 METASTASES TO PELVIS 4 0.0063
112 DERMATITIS EXFOLIATIVE GENERALISED 22 0.0063
113 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 161 0.0063
114 HEPATITIS VIRAL 5 0.0062
115 PERITONEAL DISORDER 4 0.0062
116 MAGNETIC RESONANCE IMAGING HEAD ABNORMAL 4 0.0062
117 MYCOSIS FUNGOIDES 5 0.0061
118 CHRONIC MYELOMONOCYTIC LEUKAEMIA 4 0.0061
119 RETINAL DETACHMENT 54 0.0059
120 ATRIAL TACHYCARDIA 12 0.0057
121 SARCOIDOSIS 27 0.0057
122 METASTASIS 39 0.0055
123 TUMOUR PAIN 7 0.0053
124 BRAIN STEM HAEMORRHAGE 5 0.0053
125 INTRACRANIAL MASS 5 0.0053
126 ELECTROCARDIOGRAM CHANGE 5 0.0053
127 SQUAMOUS CELL CARCINOMA OF LUNG 4 0.0052
128 METASTASES TO PERITONEUM 13 0.0051
129 MONOPARESIS 9 0.0050
130 SMALL INTESTINAL HAEMORRHAGE 10 0.0050
131 RASH GENERALISED 127 0.0049
132 NEUROLOGICAL DECOMPENSATION 11 0.0047
133 BRAIN NEOPLASM 43 0.0047
134 BONE NEOPLASM 5 0.0046
135 TRANSITIONAL CELL CARCINOMA 6 0.0046
136 ELECTROCARDIOGRAM QT PROLONGED 163 0.0045
137 RASH PUSTULAR 33 0.0045
138 CHOLANGITIS SCLEROSING 9 0.0044
139 ADENOCARCINOMA GASTRIC 4 0.0043
140 RENAL FUNCTION TEST ABNORMAL 20 0.0043
141 LIPASE INCREASED 33 0.0043
142 VITILIGO 10 0.0043
143 ALVEOLITIS 6 0.0042
144 CYSTOID MACULAR OEDEMA 8 0.0042
145 LYMPHADENOPATHY MEDIASTINAL 8 0.0042
146 HEPATOTOXICITY 92 0.0041
147 SKIN REACTION 58 0.0041
148 NEUROENDOCRINE CARCINOMA OF THE SKIN 4 0.0041
149 THERMAL BURN 29 0.0041
150 MUCOSAL DRYNESS 8 0.0040
151 ASTIGMATISM 6 0.0040
152 BRAIN OPERATION 9 0.0039
153 PARAPARESIS 7 0.0039
154 NIPPLE PAIN 8 0.0039
155 IMMUNE-MEDIATED HEPATITIS 8 0.0039
156 BLOOD BILIRUBIN ABNORMAL 5 0.0039
157 ADENOCARCINOMA PANCREAS 5 0.0039
158 METASTASES TO SKIN 4 0.0039
159 LYMPHANGIOSIS CARCINOMATOSA 4 0.0038
160 EJECTION FRACTION DECREASED 59 0.0038
161 AMYLASE INCREASED 14 0.0038
162 PROTEIN TOTAL INCREASED 10 0.0038
163 HEPATOCELLULAR INJURY 53 0.0037
164 ADENOCARCINOMA OF COLON 7 0.0037
165 GUILLAIN-BARRE SYNDROME 18 0.0037
166 GENERALISED ERYTHEMA 21 0.0037
167 LIP BLISTER 10 0.0037
168 ACNE PUSTULAR 3 0.0037
169 PILOERECTION 4 0.0037
170 ORAL FUNGAL INFECTION 10 0.0036
171 STEVENS-JOHNSON SYNDROME 81 0.0036
172 CHOLESTATIC LIVER INJURY 8 0.0036
173 RASH 1554 0.0036
174 SKIN HYPERTROPHY 10 0.0036
175 CHOLESTASIS 67 0.0035
176 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 81 0.0035
177 FAT TISSUE INCREASED 5 0.0034
178 DRUG ERUPTION 61 0.0034
179 ABDOMINAL NEOPLASM 3 0.0034
180 DECREASED ACTIVITY 36 0.0033
181 NEPHRITIS 11 0.0033
182 HYPERTRICHOSIS 6 0.0032
183 FACE OEDEMA 54 0.0032
184 BLOOD CREATINE PHOSPHOKINASE INCREASED 92 0.0032
185 ERYSIPELAS 16 0.0032
186 RETINAL OEDEMA 6 0.0031
187 RETINAL VEIN OCCLUSION 9 0.0031
188 OROPHARYNGEAL BLISTERING 5 0.0031
189 GAMMA-GLUTAMYLTRANSFERASE INCREASED 68 0.0031
190 HYPERAEMIA 6 0.0030
191 CARDIOACTIVE DRUG LEVEL INCREASED 4 0.0030
192 LYMPHOPENIA 43 0.0030
193 SEBORRHOEIC DERMATITIS 5 0.0030
194 METASTATIC NEOPLASM 13 0.0030
195 HYPERTHYROIDISM 43 0.0030
196 BLOOD BILIRUBIN INCREASED 80 0.0030
197 INTENTIONAL PRODUCT USE ISSUE 257 0.0029
198 SKIN DEPIGMENTATION 4 0.0029
199 MACULE 8 0.0029
200 KIDNEY FIBROSIS 5 0.0029
201 ALOPECIA 563 0.0029
202 MACULAR OEDEMA 16 0.0029
203 BLISTER 160 0.0028
204 PRERENAL FAILURE 4 0.0028
205 METASTASES TO LYMPH NODES 19 0.0028
206 HYPERTHERMIA 21 0.0027
207 EOSINOPHILIA 48 0.0027
208 BLOOD ALKALINE PHOSPHATASE INCREASED 68 0.0027
209 PERIPHERAL SENSORY NEUROPATHY 16 0.0027
210 PANCREATIC ENZYMES INCREASED 4 0.0027
211 SUBCUTANEOUS ABSCESS 13 0.0027
212 PAPILLOEDEMA 12 0.0027
213 GINGIVAL HYPERTROPHY 4 0.0026
214 MUCOSAL INFLAMMATION 69 0.0026
215 BASAL CELL CARCINOMA 41 0.0026
216 FACIAL PARALYSIS 22 0.0026
217 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 6 0.0026
218 FOLLICULITIS 27 0.0026
219 TOXIC EPIDERMAL NECROLYSIS 39 0.0026
220 CARDIAC TAMPONADE 12 0.0025
221 PNEUMONIA VIRAL 8 0.0025
222 ARTHRALGIA 1043 0.0025
223 PURPURA 22 0.0025
224 HYPERCHOLESTEROLAEMIA 24 0.0025
225 SKIN LESION 68 0.0025
226 ACUTE LEUKAEMIA 4 0.0025
227 NECK MASS 7 0.0025
228 LYMPHOEDEMA 17 0.0025
229 GLOMERULONEPHRITIS 6 0.0024
230 DIVERTICULAR PERFORATION 5 0.0024
231 METASTASES TO LUNG 28 0.0024
232 POOR QUALITY SLEEP 52 0.0024
233 TRANSAMINASES INCREASED 53 0.0024
234 BRAIN OEDEMA 30 0.0024
235 STAPHYLOCOCCUS TEST POSITIVE 5 0.0024
236 LEUKAEMIA RECURRENT 4 0.0024
237 HYPERPYREXIA 10 0.0024
238 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 9 0.0024
239 DERMATITIS BULLOUS 17 0.0023
240 DERMATITIS 49 0.0023
241 VIITH NERVE PARALYSIS 8 0.0023
242 HYPERBILIRUBINAEMIA 24 0.0023
243 HEPATITIS 59 0.0023
244 IRITIS 7 0.0023
245 PAPILLARY THYROID CANCER 4 0.0023
246 DECREASED APPETITE 534 0.0023
247 DYSAESTHESIA 7 0.0023
248 BURNS SECOND DEGREE 4 0.0023
249 INDURATION 4 0.0022
250 PARESIS 5 0.0022
251 DYSGEUSIA 166 0.0022
252 RASH PAPULAR 50 0.0022
253 DISTRIBUTIVE SHOCK 5 0.0022
254 VENOUS OCCLUSION 4 0.0022
255 HYPERAESTHESIA 18 0.0022
256 SOFT TISSUE INFECTION 4 0.0022
257 PNEUMONITIS 59 0.0022
258 DYSPHAGIA 205 0.0022
259 LIVER ABSCESS 7 0.0022
260 IMPAIRED WORK ABILITY 46 0.0021
261 PYREXIA 744 0.0021
262 BLOOD CREATININE INCREASED 139 0.0021
263 ORAL CANDIDIASIS 28 0.0021
264 LUNG NEOPLASM 9 0.0021
265 MYOPIA 5 0.0021
266 MYALGIA 356 0.0021
267 METASTASES TO SPINE 7 0.0021
268 GASTROINTESTINAL TOXICITY 10 0.0021
269 PARONYCHIA 9 0.0020
270 BEHAVIOUR DISORDER 11 0.0020
271 FURUNCLE 16 0.0020
272 CELL DEATH 4 0.0020
273 NEOPLASM PROGRESSION 70 0.0020
274 BLEPHARITIS 8 0.0020
275 FACIAL PARESIS 7 0.0020
276 KERATITIS 6 0.0020
277 BUNDLE BRANCH BLOCK RIGHT 9 0.0020
278 LEFT VENTRICULAR DYSFUNCTION 13 0.0019
279 IMPAIRED SELF-CARE 4 0.0019
280 NO ADVERSE EVENT 348 0.0019
281 HEPATITIS TOXIC 5 0.0019
282 CARDIOTOXICITY 17 0.0019
283 EXFOLIATIVE RASH 5 0.0019
284 ALANINE AMINOTRANSFERASE ABNORMAL 4 0.0019
285 HYPOPHOSPHATAEMIA 14 0.0019
286 SKIN DISORDER 63 0.0019
287 VASCULITIS 22 0.0019
288 HYPERTRIGLYCERIDAEMIA 11 0.0019
289 SKIN INFECTION 21 0.0019
290 HYPERTRANSAMINASAEMIA 13 0.0019
291 AUTOIMMUNE HEPATITIS 13 0.0019
292 RASH ERYTHEMATOUS 89 0.0019
293 VITREOUS DETACHMENT 4 0.0018
294 ASPARTATE AMINOTRANSFERASE INCREASED 98 0.0018
295 CEREBELLAR SYNDROME 4 0.0018
296 PLEURITIC PAIN 5 0.0018
297 TONGUE BLISTERING 4 0.0018
298 BRAIN NEOPLASM MALIGNANT 8 0.0018
299 PERICARDITIS 30 0.0018
300 ADENOCARCINOMA 4 0.0018
301 SKIN CANCER 38 0.0018
302 LICHENOID KERATOSIS 4 0.0017
303 CEREBRAL ISCHAEMIA 9 0.0017
304 AMYLOIDOSIS 3 0.0017
305 BLOOD CREATININE ABNORMAL 6 0.0017
306 PERIORBITAL OEDEMA 9 0.0017
307 LOCAL SWELLING 30 0.0017
308 GASTRITIS EROSIVE 8 0.0017
309 ALOPECIA AREATA 3 0.0017
310 HYPERURICAEMIA 7 0.0017
311 RENAL FAILURE ACUTE 72 0.0017
312 HYPOKALAEMIA 78 0.0017
313 ALANINE AMINOTRANSFERASE INCREASED 103 0.0017
314 APHTHOUS ULCER 13 0.0017
315 ATYPICAL PNEUMONIA 5 0.0017
316 CONJUNCTIVITIS 31 0.0017
317 SCAB 19 0.0017
318 THYROIDITIS 5 0.0017
319 RASH VESICULAR 8 0.0017
320 LYMPHADENITIS 4 0.0017
321 LIVER FUNCTION TEST ABNORMAL 48 0.0016
322 PERICARDIAL EFFUSION 38 0.0016
323 HEPATIC PAIN 7 0.0016
324 UROSEPSIS 15 0.0016
325 SKIN EXFOLIATION 137 0.0016
326 RETINAL TEAR 4 0.0016
327 BODY TEMPERATURE INCREASED 33 0.0016
328 INTRACRANIAL PRESSURE INCREASED 9 0.0016
329 CHOLANGITIS 10 0.0016
330 NEPHROPATHY TOXIC 18 0.0016
331 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 12 0.0016
332 ADRENAL DISORDER 3 0.0016
333 MALIGNANT NEOPLASM PROGRESSION 160 0.0016
334 MYOSITIS 14 0.0016
335 BENIGN PROSTATIC HYPERPLASIA 8 0.0015
336 HYPOALBUMINAEMIA 12 0.0015
337 NODULE 20 0.0015
338 ERYTHEMA 314 0.0015
339 YELLOW SKIN 7 0.0015
340 CEREBRAL HAEMATOMA 5 0.0015
341 ANAL ABSCESS 8 0.0015
342 HEPATIC ENZYME INCREASED 101 0.0015
343 CEREBRAL HAEMORRHAGE 53 0.0015
344 CHEILITIS 8 0.0015
345 NEOPLASM RECURRENCE 5 0.0015
346 GASTRIC PERFORATION 4 0.0015
347 PANCREATITIS ACUTE 33 0.0015
348 CYST 18 0.0014
349 VITREOUS HAEMORRHAGE 4 0.0014
350 LIVER FUNCTION TEST INCREASED 31 0.0014
351 AGEUSIA 36 0.0014
352 DERMATITIS ALLERGIC 18 0.0014
353 ANAL HAEMORRHAGE 4 0.0014
354 PROCTITIS 4 0.0014
355 PHOTOPSIA 9 0.0014
356 METASTASES TO LIVER 25 0.0014
357 RENAL TUBULAR DISORDER 4 0.0014
358 HAIR TEXTURE ABNORMAL 19 0.0014
359 PAPULE 10 0.0014
360 JAUNDICE CHOLESTATIC 5 0.0014
361 MACULOPATHY 5 0.0014
362 TORSADE DE POINTES 11 0.0014
363 NEUROLOGICAL SYMPTOM 8 0.0014
364 COLITIS 53 0.0014
365 MYOCARDITIS 16 0.0014
366 BLOOD URIC ACID INCREASED 8 0.0014
367 STRESS CARDIOMYOPATHY 8 0.0014
368 CEREBRAL DISORDER 10 0.0014
369 MENINGITIS ASEPTIC 6 0.0013
370 DEHYDRATION 178 0.0013
371 FATIGUE 1039 0.0013
372 ACUTE CORONARY SYNDROME 11 0.0013
373 PANCREATITIS 70 0.0013
374 ACNE 99 0.0013
375 LYMPHOCYTE COUNT DECREASED 23 0.0013
376 ENCEPHALITIS 9 0.0013
377 LOCALISED OEDEMA 6 0.0013
378 PIGMENTATION DISORDER 8 0.0013
379 PERFORMANCE STATUS DECREASED 6 0.0013
380 DRUG RESISTANCE 33 0.0013
381 SPINAL CORD COMPRESSION 5 0.0013
382 DIARRHOEA 828 0.0013
383 SWELLING 120 0.0013
384 DUODENAL ULCER 9 0.0013
385 ELECTROCARDIOGRAM ABNORMAL 10 0.0013
386 RENAL FAILURE 169 0.0013
387 NAIL DISCOLOURATION 5 0.0013
388 SWELLING FACE 82 0.0013
389 HEPATIC FUNCTION ABNORMAL 47 0.0013
390 HEART RATE ABNORMAL 7 0.0013
391 GENERAL PHYSICAL HEALTH DETERIORATION 145 0.0013
392 SPINAL OSTEOARTHRITIS 11 0.0013
393 INTESTINAL PERFORATION 14 0.0012
394 SKIN ULCER 32 0.0012
395 AGRANULOCYTOSIS 23 0.0012
396 RASH PRURITIC 67 0.0012
397 DEATH 1065 0.0012
398 MOUTH ULCERATION 26 0.0012
399 HEPATIC NEOPLASM 4 0.0012
400 OCULAR HYPERAEMIA 58 0.0012
401 ANAEMIA 232 0.0012
402 HYPERGLYCAEMIA 44 0.0012
403 HEPATIC ENZYME ABNORMAL 6 0.0012
404 LEUKOPENIA 60 0.0012
405 CYTOKINE RELEASE SYNDROME 24 0.0012
406 LIP OEDEMA 5 0.0012
407 ACUTE KIDNEY INJURY 180 0.0012
408 STOMATITIS 71 0.0012
409 PUSTULAR PSORIASIS 4 0.0012
410 LEFT VENTRICULAR FAILURE 4 0.0012
411 DRY SKIN 155 0.0012
412 GRANULOMA 4 0.0012
413 HYPONATRAEMIA 65 0.0012
414 CARDIOMYOPATHY 17 0.0011
415 POLYARTHRITIS 6 0.0011
416 ATRIAL FLUTTER 9 0.0011
417 RHABDOMYOLYSIS 47 0.0011
418 FIBRIN D DIMER INCREASED 4 0.0011
419 CONJUNCTIVAL HYPERAEMIA 4 0.0011
420 VISION BLURRED 154 0.0011
421 NERVOUS SYSTEM DISORDER 35 0.0011
422 OEDEMA 60 0.0011
423 LIVER DISORDER 49 0.0011
424 PROTEINURIA 21 0.0011
425 OESOPHAGITIS 12 0.0011
426 CUTANEOUS VASCULITIS 4 0.0011
427 VENTRICULAR ARRHYTHMIA 4 0.0011
428 ASTHENOPIA 6 0.0011
429 POLYNEUROPATHY 13 0.0011
430 INTERCEPTED MEDICATION ERROR 5 0.0011
431 C-REACTIVE PROTEIN INCREASED 39 0.0011
432 PHOTOPHOBIA 20 0.0011
433 AUTOIMMUNE THYROIDITIS 4 0.0011
434 VISUAL IMPAIRMENT 131 0.0011
435 COLITIS MICROSCOPIC 5 0.0011
436 CHILLS 123 0.0010
437 EYE INFLAMMATION 10 0.0010
438 HYPERTONIA 6 0.0010
439 SUPRAVENTRICULAR TACHYCARDIA 10 0.0010
440 GASTRITIS 27 0.0010
441 NAUSEA 812 0.0010
442 SPINAL PAIN 12 0.0010
443 TUMOUR LYSIS SYNDROME 9 0.0010
444 SKIN ODOUR ABNORMAL 4 0.0010
445 PRURITUS 390 0.0010
446 EPILEPSY 31 0.0010
447 VOMITING 475 0.0010
448 CARDIAC FAILURE 81 0.0010
449 CHOLECYSTITIS 12 0.0010
450 ODYNOPHAGIA 6 0.0010
451 OESOPHAGEAL CANDIDIASIS 4 0.0010
452 HEMIPARESIS 17 0.0010
453 HAEMORRHAGE INTRACRANIAL 15 0.0010
454 PERIPHERAL SWELLING 154 0.0010
455 OFF LABEL USE 875 0.0010
456 ACNE CYSTIC 3 0.0010
457 PNEUMOCYSTIS JIROVECII PNEUMONIA 10 0.0010
458 DRUG-INDUCED LIVER INJURY 31 0.0010
459 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 5 0.0010
460 SKIN DISCOLOURATION 45 0.0010
461 HICCUPS 8 0.0010
462 CHROMATURIA 22 0.0010
463 LARYNGEAL OEDEMA 6 0.0010
464 GENERALISED OEDEMA 12 0.0010
465 EMBOLISM 8 0.0010
466 EOSINOPHIL COUNT INCREASED 8 0.0010
467 NEUTROPHIL COUNT DECREASED 39 0.0010
468 EYELID OEDEMA 11 0.0009
469 CENTRAL NERVOUS SYSTEM LESION 13 0.0009
470 LYMPHADENOPATHY 33 0.0009
471 SKIN HYPERPIGMENTATION 8 0.0009
472 ASTHENIA 349 0.0009
473 BACTERAEMIA 11 0.0009
474 ANGIOEDEMA 41 0.0009
475 HORDEOLUM 4 0.0009
476 OCULAR ICTERUS 4 0.0009
477 HYDROCEPHALUS 5 0.0009
478 RENAL TUBULAR NECROSIS 9 0.0009
479 VENTRICULAR TACHYCARDIA 15 0.0009
480 ADVERSE REACTION 12 0.0009
481 BLOOD CREATINE INCREASED 4 0.0009
482 VISUAL ACUITY REDUCED 30 0.0009
483 HYPERTENSIVE CRISIS 10 0.0009
484 NECROSIS 5 0.0009
485 THERAPY PARTIAL RESPONDER 14 0.0009
486 ATRIAL FIBRILLATION 87 0.0009
487 HYPERCALCAEMIA 11 0.0009
488 IRON DEFICIENCY 4 0.0009
489 CANDIDA INFECTION 15 0.0009
490 URINARY TRACT DISORDER 4 0.0009
491 BLOOD DISORDER 7 0.0009
492 ISCHAEMIA 4 0.0009
493 SENSORY LOSS 7 0.0009
494 HAIR GROWTH ABNORMAL 6 0.0009
495 LARGE INTESTINE PERFORATION 6 0.0009
496 HEPATIC FAILURE 26 0.0009
497 SEPSIS 96 0.0009
498 EXTRASYSTOLES 6 0.0009
499 RASH MACULAR 30 0.0009
500 DISSEMINATED INTRAVASCULAR COAGULATION 12 0.0009
501 ABASIA 21 0.0008
502 THROMBOCYTOPENIA 95 0.0008
503 LEUKAEMIA 8 0.0008
504 CHRONIC LYMPHOCYTIC LEUKAEMIA 4 0.0008
505 SECOND PRIMARY MALIGNANCY 7 0.0008
506 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 8 0.0008
507 TUMOUR MARKER INCREASED 4 0.0008
508 VISUAL FIELD DEFECT 6 0.0008
509 HEPATITIS CHOLESTATIC 5 0.0008
510 ENTEROCOCCAL INFECTION 4 0.0008
511 CONSTIPATION 180 0.0008
512 NEUTROPENIA 111 0.0008
513 JOINT SWELLING 98 0.0008
514 MULTI-ORGAN FAILURE 14 0.0008
515 HYDRONEPHROSIS 6 0.0008
516 TUBULOINTERSTITIAL NEPHRITIS 15 0.0008
517 GROIN PAIN 7 0.0008
518 OEDEMA PERIPHERAL 97 0.0008
519 NEOPLASM MALIGNANT 53 0.0008
520 RENAL IMPAIRMENT 66 0.0008
521 JAUNDICE 21 0.0008
522 CACHEXIA 4 0.0008
523 HAEMOLYSIS 6 0.0008
524 MADAROSIS 9 0.0008
525 ELECTROLYTE IMBALANCE 9 0.0008
526 LEUKOCYTOSIS 14 0.0008
527 LIP DRY 7 0.0008
528 FAILURE TO THRIVE 4 0.0008
529 WEIGHT DECREASED 215 0.0008
530 PARTIAL SEIZURES 4 0.0008
531 GASTROENTERITIS 11 0.0008
532 HYPERLIPIDAEMIA 9 0.0008
533 MENINGITIS 5 0.0007
534 ASCITES 22 0.0007
535 BRONCHIECTASIS 5 0.0007
536 ADRENAL INSUFFICIENCY 9 0.0007
537 GINGIVITIS 4 0.0007
538 PLEURAL EFFUSION 45 0.0007
539 GENERAL PHYSICAL CONDITION ABNORMAL 5 0.0007
540 PULMONARY THROMBOSIS 8 0.0007
541 GINGIVAL BLEEDING 10 0.0007
542 SMALL INTESTINAL OBSTRUCTION 9 0.0007
543 METASTASES TO BONE 12 0.0007
544 APHASIA 22 0.0007
545 LACRIMATION INCREASED 22 0.0007
546 EYE SWELLING 27 0.0007
547 FEBRILE NEUTROPENIA 48 0.0007
548 HAIR COLOUR CHANGES 9 0.0007
549 ANGIOPATHY 4 0.0007
550 ACUTE PULMONARY OEDEMA 4 0.0007
551 VITREOUS FLOATERS 7 0.0007
552 PAIN OF SKIN 19 0.0007
553 VERTIGO 43 0.0007
554 EATING DISORDER 15 0.0007
555 MYOCARDIAL ISCHAEMIA 8 0.0007
556 BLOOD POTASSIUM DECREASED 21 0.0007
557 ARRHYTHMIA 33 0.0007
558 PAIN IN EXTREMITY 205 0.0007
559 MYOPATHY 6 0.0007
560 HERPES VIRUS INFECTION 4 0.0007
561 NEUROPATHY PERIPHERAL 66 0.0007
562 PYELONEPHRITIS 6 0.0007
563 ENCEPHALOPATHY 17 0.0007
564 ULCER 11 0.0007
565 MOTOR DYSFUNCTION 7 0.0007
566 HYPOVOLAEMIA 4 0.0007
567 ORAL DISORDER 5 0.0007
568 MOUTH HAEMORRHAGE 5 0.0007
569 HAEMOPTYSIS 19 0.0007
570 VENTRICULAR EXTRASYSTOLES 7 0.0007
571 HAEMATURIA 23 0.0007
572 BURNING SENSATION 47 0.0007
573 LIP SWELLING 22 0.0007
574 TENDON PAIN 5 0.0007
575 AORTIC ANEURYSM 5 0.0007
576 RENAL FAILURE CHRONIC 5 0.0006
577 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 5 0.0006
578 ILL-DEFINED DISORDER 39 0.0006
579 FEEDING DISORDER 13 0.0006
580 INTESTINAL OBSTRUCTION 24 0.0006
581 MULTIPLE ORGAN DYSFUNCTION SYNDROME 18 0.0006
582 DISORIENTATION 25 0.0006
583 MUSCULOSKELETAL PAIN 33 0.0006
584 CONVULSION 36 0.0006
585 HYPOTHYROIDISM 20 0.0006
586 APHAGIA 3 0.0006
587 STATUS EPILEPTICUS 7 0.0006
588 INCOHERENT 4 0.0006
589 BONE PAIN 36 0.0006
590 LIVER INJURY 15 0.0006
591 HEPATOMEGALY 6 0.0006
592 THERAPY CHANGE 6 0.0006
593 HEMIPLEGIA 5 0.0006
594 CARDIAC FAILURE ACUTE 4 0.0006
595 BRAIN INJURY 6 0.0006
596 JOINT RANGE OF MOTION DECREASED 8 0.0006
597 POSTOPERATIVE WOUND INFECTION 4 0.0006
598 TASTE DISORDER 12 0.0006
599 ULCER HAEMORRHAGE 4 0.0006
600 HEPATIC STEATOSIS 11 0.0006
601 BLOOD IRON DECREASED 7 0.0006
602 ATAXIA 7 0.0006
603 MUSCULAR WEAKNESS 67 0.0006
604 PNEUMONIA 190 0.0006
605 EAR DISCOMFORT 6 0.0006
606 DYSARTHRIA 22 0.0006
607 PSEUDOMONAS INFECTION 5 0.0006
608 MUSCULOSKELETAL CHEST PAIN 9 0.0006
609 JOINT EFFUSION 4 0.0006
610 LUNG INFECTION 9 0.0006
611 ACUTE MYOCARDIAL INFARCTION 17 0.0006
612 SKIN SWELLING 5 0.0006
613 CELLULITIS 29 0.0006
614 FORMICATION 4 0.0006
615 DEAFNESS 15 0.0006
616 NAIL DISORDER 5 0.0006
617 GLOMERULAR FILTRATION RATE DECREASED 7 0.0006
618 EYE PAIN 32 0.0006
619 PULMONARY TOXICITY 4 0.0006
620 FLATULENCE 32 0.0006
621 ORAL HERPES 11 0.0006
622 DRY EYE 28 0.0006
623 HAEMOLYTIC ANAEMIA 5 0.0006
624 HYPOPHAGIA 14 0.0005
625 UTERINE LEIOMYOMA 4 0.0005
626 HEADACHE 340 0.0005
627 LOWER GASTROINTESTINAL HAEMORRHAGE 4 0.0005
628 MENTAL STATUS CHANGES 15 0.0005
629 BLINDNESS 22 0.0005
630 DRUG EFFECT DECREASED 29 0.0005
631 PERSONALITY CHANGE 5 0.0005
632 PANCYTOPENIA 30 0.0005
633 DIARRHOEA HAEMORRHAGIC 5 0.0005
634 JOINT STIFFNESS 14 0.0005
635 BEDRIDDEN 7 0.0005
636 EYE INFECTION 6 0.0005
637 DYSPNOEA EXERTIONAL 20 0.0005
638 BLOOD SODIUM DECREASED 10 0.0005
639 PAROSMIA 4 0.0005
640 PEMPHIGOID 4 0.0005
641 SEPTIC SHOCK 23 0.0005
642 ACIDOSIS 4 0.0005
643 PHARYNGEAL OEDEMA 8 0.0005
644 URTICARIA 87 0.0005
645 TACHYCARDIA 46 0.0005
646 DRY MOUTH 42 0.0005
647 EYE DISORDER 17 0.0005
648 INTERSTITIAL LUNG DISEASE 25 0.0005
649 NEUROTOXICITY 9 0.0005
650 CONFUSIONAL STATE 83 0.0005
651 HAEMORRHAGIC STROKE 4 0.0005
652 OROPHARYNGEAL PAIN 47 0.0005
653 WHITE BLOOD CELL COUNT DECREASED 55 0.0005
654 HAEMATOCHEZIA 28 0.0005
655 HYPOMAGNESAEMIA 7 0.0005
656 GINGIVAL PAIN 4 0.0005
657 GOUT 9 0.0005
658 DIPLOPIA 13 0.0005
659 INFECTION 72 0.0005
660 PULMONARY EMBOLISM 47 0.0005
661 NEURALGIA 12 0.0005
662 LUNG DISORDER 24 0.0005
663 CATARACT 29 0.0005
664 ESCHERICHIA INFECTION 4 0.0005
665 MYELODYSPLASTIC SYNDROME 7 0.0005
666 PETECHIAE 5 0.0005
667 BLOOD UREA INCREASED 8 0.0005
668 HYPOCALCAEMIA 9 0.0005
669 GASTRIC ULCER 9 0.0005
670 SUDDEN DEATH 5 0.0005
671 CLOSTRIDIUM DIFFICILE COLITIS 5 0.0005
672 HEPATIC CYTOLYSIS 6 0.0005
673 PLATELET COUNT DECREASED 50 0.0005
674 RESPIRATORY FAILURE 34 0.0005
675 INFLAMMATION 24 0.0005
676 HYPOAESTHESIA ORAL 7 0.0005
677 URINE OUTPUT DECREASED 4 0.0005
678 INTERVERTEBRAL DISC PROTRUSION 10 0.0005
679 ASPIRATION 5 0.0005
680 BLOOD CALCIUM INCREASED 4 0.0005
681 MELAENA 10 0.0005
682 DRUG INTERACTION 72 0.0005
683 HYPERSOMNIA 13 0.0005
684 EYE HAEMORRHAGE 6 0.0004
685 THERAPY CESSATION 23 0.0004
686 DRUG INTOLERANCE 43 0.0004
687 ARTHRITIS 35 0.0004
688 HYPERTENSION 94 0.0004
689 HEART RATE IRREGULAR 10 0.0004
690 OPTIC NEURITIS 4 0.0004
691 SYNCOPE 44 0.0004
692 SCIATICA 7 0.0004
693 ABDOMINAL PAIN 102 0.0004
694 MICTURITION URGENCY 5 0.0004
695 OVARIAN CANCER 4 0.0004
696 IRON DEFICIENCY ANAEMIA 4 0.0004
697 APPENDICITIS 4 0.0004
698 COVID-19 PNEUMONIA 5 0.0004
699 SINUS TACHYCARDIA 6 0.0004
700 RETCHING 9 0.0004
701 SPEECH DISORDER 22 0.0004
702 HERPES ZOSTER 24 0.0004
703 UPPER GASTROINTESTINAL HAEMORRHAGE 7 0.0004
704 ATELECTASIS 4 0.0004
705 AUTOIMMUNE DISORDER 4 0.0004
706 CYTOPENIA 5 0.0004
707 LABORATORY TEST ABNORMAL 12 0.0004
708 CARDIAC DISORDER 38 0.0004
709 URINARY TRACT INFECTION 69 0.0004
710 PULMONARY MASS 6 0.0004
711 ORAL PAIN 9 0.0004
712 HYPERSENSITIVITY 74 0.0004
713 RESPIRATORY DISTRESS 11 0.0004
714 SEIZURE 46 0.0004
715 HYPOACUSIS 17 0.0004
716 EYELID PTOSIS 4 0.0004
717 HAEMORRHAGE 41 0.0004
718 FEELING HOT 24 0.0004
719 THYROID DISORDER 6 0.0004
720 MYELOSUPPRESSION 14 0.0004
721 DYSPNOEA 220 0.0004
722 SYNOVITIS 7 0.0004
723 HYPOAESTHESIA 58 0.0004
724 RENAL DISORDER 18 0.0004
725 TREATMENT FAILURE 32 0.0004
726 ANGINA PECTORIS 11 0.0004
727 TENDERNESS 4 0.0004
728 TRANSFUSION 4 0.0004
729 PULMONARY OEDEMA 17 0.0004
730 HYPOTENSION 76 0.0004
731 INCONTINENCE 4 0.0004
732 PRODUCT PRESCRIBING ERROR 9 0.0004
733 FLUSHING 38 0.0004
734 NIGHT SWEATS 12 0.0004
735 HYPOXIA 13 0.0004
736 MUSCULOSKELETAL DISORDER 7 0.0004
737 WOUND INFECTION 4 0.0004
738 PULMONARY FIBROSIS 7 0.0004
739 ACUTE RESPIRATORY FAILURE 7 0.0004
740 HEART RATE INCREASED 36 0.0004
741 DIVERTICULITIS 10 0.0004
742 THROMBOSIS 29 0.0004
743 COUGH 101 0.0004
744 APHONIA 5 0.0004
745 MALNUTRITION 4 0.0004
746 PAIN 219 0.0004
747 BLOOD TEST ABNORMAL 5 0.0004
748 FEMUR FRACTURE 11 0.0004
749 MITRAL VALVE INCOMPETENCE 4 0.0004
750 DYSURIA 13 0.0004
751 SWOLLEN TONGUE 11 0.0004
752 CHOLECYSTECTOMY 4 0.0003
753 PARALYSIS 5 0.0003
754 ANURIA 3 0.0003
755 GASTROINTESTINAL HAEMORRHAGE 29 0.0003
756 PARAESTHESIA 54 0.0003
757 HIP FRACTURE 11 0.0003
758 DYSPHONIA 20 0.0003
759 SPLENOMEGALY 4 0.0003
760 SKIN HAEMORRHAGE 5 0.0003
761 COLON CANCER 5 0.0003
762 THERAPY NON-RESPONDER 15 0.0003
763 TOXICITY TO VARIOUS AGENTS 56 0.0003
764 HAEMOGLOBIN DECREASED 34 0.0003
765 ABDOMINAL PAIN UPPER 68 0.0003
766 BLOOD COUNT ABNORMAL 5 0.0003
767 EYE PRURITUS 11 0.0003
768 RECTAL HAEMORRHAGE 14 0.0003
769 DEVICE RELATED INFECTION 5 0.0003
770 BALANCE DISORDER 28 0.0003
771 TENDONITIS 5 0.0003
772 WOUND 9 0.0003
773 THERAPY INTERRUPTED 23 0.0003
774 PNEUMOTHORAX 5 0.0003
775 CYSTITIS 10 0.0003
776 ABSCESS 5 0.0003
777 INTRAOCULAR PRESSURE INCREASED 4 0.0003
778 WHITE BLOOD CELL COUNT INCREASED 12 0.0003
779 SENSORY DISTURBANCE 5 0.0003
780 HAEMATOMA 8 0.0003
781 RESPIRATORY TRACT INFECTION 8 0.0003
782 CEREBROVASCULAR ACCIDENT 52 0.0003
783 IMMUNE SYSTEM DISORDER 4 0.0003
784 CHEST PAIN 56 0.0003
785 BACK PAIN 69 0.0003
786 CIRCULATORY COLLAPSE 5 0.0003
787 DRUG ADMINISTRATION ERROR 9 0.0003
788 ACUTE HEPATIC FAILURE 4 0.0003
789 OSTEOPOROSIS 12 0.0003
790 PERIPHERAL COLDNESS 4 0.0003
791 PERITONITIS 6 0.0003
792 ORAL DISCOMFORT 4 0.0003
793 POLLAKIURIA 12 0.0003
794 COORDINATION ABNORMAL 4 0.0003
795 NECK PAIN 16 0.0003
796 INSOMNIA 76 0.0003
797 BLINDNESS UNILATERAL 4 0.0003
798 ACUTE RESPIRATORY DISTRESS SYNDROME 5 0.0003
799 UPPER RESPIRATORY TRACT INFECTION 13 0.0003
800 BRONCHOSPASM 4 0.0003
801 RED BLOOD CELL COUNT DECREASED 8 0.0003
802 INFLUENZA LIKE ILLNESS 23 0.0003
803 LETHARGY 16 0.0003
804 PRURITUS GENERALISED 6 0.0003
805 HYPOKINESIA 4 0.0003
806 PRODUCT DISPENSING ERROR 6 0.0003
807 MYOCARDIAL INFARCTION 48 0.0003
808 DYSPEPSIA 27 0.0003
809 BONE DISORDER 5 0.0003
810 IMPAIRED HEALING 9 0.0003
811 COMA 13 0.0003
812 MALAISE 118 0.0003
813 IMMUNODEFICIENCY 4 0.0003
814 BACTERIAL INFECTION 5 0.0003
815 GASTROINTESTINAL DISORDER 24 0.0003
816 ECZEMA 14 0.0003
817 GAIT DISTURBANCE 51 0.0003
818 GASTRIC DISORDER 9 0.0003
819 AMNESIA 17 0.0003
820 SHOCK 6 0.0003
821 EYE IRRITATION 15 0.0003
822 DELIRIUM 9 0.0003
823 ERUCTATION 5 0.0003
824 HYPERKALAEMIA 9 0.0003
825 KIDNEY INFECTION 5 0.0003
826 ACTIVITIES OF DAILY LIVING IMPAIRED 5 0.0003
827 SKIN BURNING SENSATION 18 0.0003
828 MOVEMENT DISORDER 8 0.0002
829 MENTAL IMPAIRMENT 6 0.0002
830 DEEP VEIN THROMBOSIS 16 0.0002
831 INTERNATIONAL NORMALISED RATIO INCREASED 7 0.0002
832 CHOLELITHIASIS 8 0.0002
833 BRONCHITIS 18 0.0002
834 STAPHYLOCOCCAL INFECTION 8 0.0002
835 INFUSION RELATED REACTION 16 0.0002
836 CYTOMEGALOVIRUS INFECTION 4 0.0002
837 VIRAL INFECTION 8 0.0002
838 FUNGAL INFECTION 8 0.0002
839 TINNITUS 11 0.0002
840 GAIT INABILITY 8 0.0002
841 PALPITATIONS 28 0.0002
842 TRANSIENT ISCHAEMIC ATTACK 8 0.0002
843 HAEMATEMESIS 6 0.0002
844 CARDIAC FAILURE CONGESTIVE 19 0.0002
845 CARDIOVASCULAR DISORDER 6 0.0002
846 URINARY INCONTINENCE 7 0.0002
847 BLOOD CHOLESTEROL INCREASED 11 0.0002
848 ANAPHYLACTIC REACTION 13 0.0002
849 RESPIRATORY DISORDER 7 0.0002
850 ARTHROPATHY 13 0.0002
851 ANAPHYLACTIC SHOCK 6 0.0002
852 FAECES DISCOLOURED 5 0.0002
853 CLOSTRIDIUM DIFFICILE INFECTION 5 0.0002
854 SOMNOLENCE 46 0.0002
855 AMENORRHOEA 4 0.0002
856 DIABETES MELLITUS INADEQUATE CONTROL 4 0.0002
857 HEAD DISCOMFORT 4 0.0002
858 DIABETES MELLITUS 17 0.0002
859 GASTROENTERITIS VIRAL 4 0.0002
860 DYSKINESIA 9 0.0002
861 RESTLESS LEGS SYNDROME 4 0.0002
862 METABOLIC ACIDOSIS 7 0.0002
863 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 12 0.0002
864 MEMORY IMPAIRMENT 30 0.0002
865 SKIN IRRITATION 10 0.0002
866 MUSCULOSKELETAL STIFFNESS 19 0.0002
867 CHEST DISCOMFORT 22 0.0002
868 PRODUCT USE IN UNAPPROVED INDICATION 53 0.0002
869 DISCOMFORT 13 0.0002
870 ABDOMINAL DISTENSION 22 0.0002
871 LOSS OF CONSCIOUSNESS 27 0.0002
872 BLOOD URINE PRESENT 4 0.0002
873 INCREASED APPETITE 4 0.0002
874 MOBILITY DECREASED 15 0.0002
875 ABDOMINAL DISCOMFORT 35 0.0002
876 BLOOD PRESSURE FLUCTUATION 5 0.0002
877 ANOSMIA 3 0.0002
878 LOCALISED INFECTION 5 0.0002
879 APATHY 3 0.0002
880 PRESYNCOPE 5 0.0002
881 CHOKING 4 0.0002
882 TREMOR 34 0.0002
883 SKIN FISSURES 4 0.0002
884 PSYCHOTIC DISORDER 6 0.0002
885 BLOOD PRESSURE INCREASED 31 0.0002
886 UPPER LIMB FRACTURE 4 0.0002
887 EPISTAXIS 15 0.0002
888 DIZZINESS 100 0.0002
889 SPINAL FRACTURE 4 0.0002
890 HALLUCINATION 15 0.0002
891 FULL BLOOD COUNT DECREASED 4 0.0002
892 LOWER RESPIRATORY TRACT INFECTION 9 0.0002
893 ABDOMINAL PAIN LOWER 5 0.0002
894 CONTUSION 19 0.0002
895 BONE MARROW FAILURE 4 0.0002
896 FLUID RETENTION 10 0.0002
897 MUSCLE SPASMS 36 0.0002
898 LUNG NEOPLASM MALIGNANT 8 0.0002
899 COGNITIVE DISORDER 9 0.0002
900 ACUTE MYELOID LEUKAEMIA 3 0.0002
901 FALL 64 0.0002
902 PULMONARY HYPERTENSION 4 0.0002
903 RESTLESSNESS 7 0.0002
904 DRUG INEFFECTIVE 251 0.0002
905 DEPRESSION 43 0.0002
906 OSTEOARTHRITIS 8 0.0002
907 PRODUCTIVE COUGH 9 0.0002
908 FREQUENT BOWEL MOVEMENTS 5 0.0002
909 UNEVALUABLE EVENT 14 0.0002
910 THROAT TIGHTNESS 5 0.0002
911 SLEEP DISORDER 13 0.0002
912 FEELING COLD 5 0.0002
913 PLASMA CELL MYELOMA 7 0.0002
914 COLITIS ULCERATIVE 8 0.0002
915 DEMENTIA 5 0.0002
916 THROAT IRRITATION 8 0.0002
917 NEPHROLITHIASIS 8 0.0002
918 GASTROOESOPHAGEAL REFLUX DISEASE 14 0.0002
919 MUSCLE TWITCHING 4 0.0002
920 PANCREATIC CARCINOMA 5 0.0002
921 DYSSTASIA 5 0.0002
922 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 12 0.0002
923 DIABETIC KETOACIDOSIS 4 0.0002
924 CEREBRAL INFARCTION 4 0.0002
925 HOSPITALISATION 25 0.0002
926 EXTRAPYRAMIDAL DISORDER 4 0.0002
927 MENTAL DISORDER 7 0.0002
928 PNEUMONIA ASPIRATION 4 0.0002
929 ADVERSE DRUG REACTION 14 0.0002
930 DEPRESSED LEVEL OF CONSCIOUSNESS 6 0.0002
931 ABNORMAL BEHAVIOUR 6 0.0002
932 EAR INFECTION 4 0.0002
933 ANXIETY 42 0.0001
934 DISEASE RECURRENCE 7 0.0001
935 PALLOR 4 0.0001
936 MOOD ALTERED 4 0.0001
937 HOT FLUSH 11 0.0001
938 MEDICATION ERROR 8 0.0001
939 ALTERED STATE OF CONSCIOUSNESS 3 0.0001
940 INTENTIONAL PRODUCT MISUSE 12 0.0001
941 UNDERDOSE 10 0.0001
942 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 4 0.0001
943 BLOOD PRESSURE DECREASED 9 0.0001
944 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 7 0.0001
945 THERAPEUTIC PRODUCT EFFECT DECREASED 6 0.0001
946 CORONARY ARTERY DISEASE 4 0.0001
947 GYNAECOMASTIA 4 0.0001
948 LIMB DISCOMFORT 4 0.0001
949 SINUSITIS 13 0.0001
950 INFLUENZA 14 0.0001
951 NASOPHARYNGITIS 23 0.0001
952 CARDIAC ARREST 10 0.0001
953 URINARY RETENTION 4 0.0001
954 SURGERY 7 0.0001
955 ILLNESS 12 0.0001
956 BRADYCARDIA 6 0.0001
957 WRONG TECHNIQUE IN DRUG USAGE PROCESS 4 0.0001
958 CRYING 4 0.0001
959 ACCIDENTAL OVERDOSE 4 0.0001
960 FEELING ABNORMAL 26 0.0001
961 CONDITION AGGRAVATED 32 0.0001
962 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 21 0.0001
963 HYPOGLYCAEMIA 5 0.0001
964 SUICIDAL IDEATION 9 0.0001
965 WEIGHT INCREASED 21 0.0001
966 HYPERHIDROSIS 12 0.0001
967 RHINORRHOEA 6 0.0001
968 DISTURBANCE IN ATTENTION 5 0.0001
969 VAGINAL HAEMORRHAGE 4 0.0001
970 CHRONIC KIDNEY DISEASE 7 0.0001
971 PRODUCT STORAGE ERROR 8 0.0001
972 PROSTATE CANCER 7 0.0001
973 BREAST CANCER 8 0.0001
974 THERAPEUTIC RESPONSE DECREASED 5 0.0001
975 AGITATION 6 0.0001
976 COVID-19 14 0.0001
977 DRUG DOSE OMISSION 13 0.0001
978 DEPRESSED MOOD 4 0.0001
979 BLOOD GLUCOSE INCREASED 13 0.0001
980 INCORRECT DOSE ADMINISTERED 15 0.0001
981 RHEUMATOID ARTHRITIS 7 0.0001
982 PRODUCT DOSE OMISSION 4 0.0001
983 PRODUCT DOSE OMISSION ISSUE 16 0.0001
984 PRODUCT USE ISSUE 10 0.0001
985 MIGRAINE 5 0.0001
986 FOETAL EXPOSURE DURING PREGNANCY 4 0.0000
987 OVERDOSE 10 0.0000
988 MATERNAL EXPOSURE DURING PREGNANCY 4 0.0000
989 INJECTION SITE PAIN 10 0.0000
990 ADVERSE EVENT 3 0.0000
991 PRODUCT QUALITY ISSUE 4 0.0000